Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure

Abstract

Acute kidney injury (AKI) is a common clinical syndrome directly related to patient short-term and long-term morbidity and mortality. Over the last decade, the occurrence rate of AKI has been increasing, and there has also been a growing epidemic of chronic kidney diseases (CKD) and end-stage kidney disease (ESRD) linked to severe and repeated episodes of AKIs. The detection and management of AKI are currently far from satisfactory. A large proportion of AKI patients, especially those with preexisting CKD, are at an increased risk of non-resolving AKI and progressing to CKD and ESRD. Proposed pathological processes that contribute to the transition of AKI to CKD and ESRD include severity and frequency of kidney injury, alterations of tubular cell phenotype with cells predominantly in the G2/M phase, interstitial fibrosis and microvascular rarification related to loss of endothelial-pericyte interactions and pericyte dedifferentiation. Innate immune responses, especially dendritic cell responses related to inadequate adenosine receptor (2a)-mediated signals, autophagic insufficiency and renin-angiotensin system activation have also been implicated in the progression of AKI and transitions from AKI to CKD and ESRD. Although promising advances have been made in understanding the pathophysiology of AKI and AKI consequences, much more work needs to be done in developing biomarkers for detecting early kidney injury, prognosticating kidney disease progression and developing strategies to effectively treat AKI and to minimize AKI progression to CKD and ESRD.

Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study

“…Furthermore, it was seen that the development of AKI in itself was a significant and independent risk factor for future AKI and this was directly related to the number of AKI episodes. This is possibly because of loss of renal reserve with decline in the number of functional nephrons, maladaptive vascular and tubular repair with each episode of AKI which predisposes these patients to future episodes of AKI . Interestingly, the decline in eGFR in these patients also correlated significantly with the presence and number of AKI episodes again highlighting that each AKI episode may compromise the functional renal mass and therefore the estimated glomerular filtration rate.…”

Inhibition of PTEN Activity Aggravates Post Renal Fibrosis in Mice with Ischemia Reperfusion-Induced Acute Kidney Injury

“…In recent years, there have been a number of studies about progressive CKD following AKI [30-32]. However, the molecular mechanism of AKI-induced renal fibrosis, which is the main pathological feature of CKD, remains unclear.…”

The protective effects of Zhen-Wu-Tang against cisplatin-induced acute kidney injury in rats

“…Recent basic science and epidemiologic studies have further suggested a causal role of AKI in the development and progression of chronic kidney disease[15,16]. ZWT is a traditional Chinese medicine whose recipe was recorded in the book “Treatise on Febrile Diseases”, which was written by Zhongjing Zhang during the Ming dynasty, and it has been used for the clinical treatment of kidney impairments.…”